
AVANTOR INC
AVTRNYSETrading Snapshot
- Day Range
- $356.77 β $366.08
- 52-Week Range
- $7.27 β $15.93
- Volume
- $2.11B
- Avg Volume
- $2.23B
- Shares Outstanding
- 676.4M
- Next Earnings
- Oct 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $6.55B
- Last Q Revenue
- $1.69B
- P/E Ratio
- β
- P/S Ratio
- 1.4x
- EPS (TTM)
- $-0.85
- Dividend Yield
- β
Why Investors Own AVTR
- βHigh-growth profile β revenue up +59.2% YoY with expanding US Equity exposure.
- βHealthy economics β 28% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About AVANTOR INC
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
AVANTOR INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift AVTR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
AVANTOR INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.